Why is DNLI up?
Up 8% on Nov 4, an up day for the market: the S&P 500 rose 2%, 72% of stocks rose, and biotech stocks a median 2.1%.
“AVLAYAH's U.S. launch gained significant momentum, driven by strong demand from families across the eligible patient population”
Why DNLI still lags the market over five years
Down 59% over the five years to Nov 20 while the S&P 500 rose 58%; up 8% on Nov 4.
3 reasons, from its filings, with the timeline and its peers, for Pro members.